Hemostemix Inc (HEM) — Strategic Asset Allocation Index
Hemostemix Inc (HEM) has a Strategic Asset Allocation Index of 1.4% as of September 2017. Strategic assets (PP&E of CA$73.17K plus long-term investments of CA$-) total CA$73.17K, measured against net assets of CA$5.40 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See HEM net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Hemostemix Inc Strategic Asset Allocation Index (2013–2015)
This chart shows how Hemostemix Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2013 to 2015. As of September 2017, the index stands at 1.4%, representing strategic assets of CA$73.17K against net assets of CA$5.40 Million CAD. For live market cap and overall valuation, see HEM stock market capitalisation.
Annual Strategic Asset Allocation Index for Hemostemix Inc (2013–2015)
The table below presents the year-by-year Strategic Asset Allocation Index for Hemostemix Inc from 2013 to 2015, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See HEM book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2015 | 101.6% | CA$176.84K | CA$138.86K | CA$37.98K | CA$174.08K | ▲ +96.0 pp |
| 2014 | 5.6% | CA$190.61K | CA$152.44K | CA$38.16K | CA$3.39 Million | ▼ -26.4 pp |
| 2013 | 32.0% | CA$183.69K | CA$142.17K | CA$41.52K | CA$573.87K | — |